GLP-1s tied to elevated risk of fainting, dizziness

Article excerpt

Northwestern Medicine researchers tracking more than 42,000 adults on blood pressure medications found that GLP-1 drugs, the popular weight-loss and diabetes treatments, are tied to elevated risks of fainting, dizziness, and hypotensive events. The team analyzed health records of patients already taking at least two blood pressure medications, then monitored what happened after they started GLP-1s. The findings flag a potential safety concern for a drug class that has exploded in popularity in recent years, particularly among patients managing multiple cardiovascular conditions.